IP Library Granted Patent US 7,620,455
Granted Patent B2
US 7,620,455 · App. 11/258,764 · Granted Nov 17, 2009

Cranial nerve stimulation to treat eating disorders

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,620,455
App. No.
11/258,764
Granted
Nov 17, 2009
Kind
B2
Abstract

Methods and systems of treating a patient having an eating disorder involving coupling at least one electrode to at least one cranial nerve of the patient, implanting a sensory stimulation device in the patient, applying a sensory stimulus to the patient using the sensory stimulation device, detecting the patient's response to the sensory stimulus, and applying an electrical signal to the cranial nerve using the electrode after detecting the response to treat the eating disorder. The methods and systems are effective in treating bulimia.

Claims (11)

1. A method of treating a patient having an eating disorder using an implantable medical device, comprising:

applying a stimulus to said patient using said implantable medical device;

detecting at least one response selected from the group consisting of a refractory period, a signal latency, a synaptic latency, a synaptic jitter, and a conduction delay resulting from said stimulus;

comparing said at least one response resulting from said stimulus to at least one response associated with a predetermined threshold to detect a change in said response; and

applying an electrical signal to a portion of a vagus nerve of said patient based upon said change in said response, for treating an eating disorder of the patient.

2. The method of claim 1 , wherein detecting said refractory period comprises detecting a time period after an action potential is induced in a nerve of the patient.

3. The method of claim 1 , wherein detecting said conduction delay comprises measuring a time period between the neuronal transmission of an action potential in a nerve of the patient and the arrival of a resultant signal at a target location corresponding to said neuronal transmission.

4. The method of claim 1 , wherein detecting said signal latency comprises detecting a time period of apparent inactivity between the time a stimulus signal is applied and the time a response occurs.

5. The method of claim 4 , wherein detecting said synaptic jitter comprises detecting variability in said latency of neuronal transmission.

6. The method of claim 1 , wherein detecting said synaptic latency comprises detecting a time period between delivery of a stimulus signal and the arrival of the synaptic event at a target location.

7. The method of claim 1 , wherein said stimulus is selected from the group consisting of a noxious stimulus, a pain stimulus, a temperature stimulus, and a discomfort stimulus.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: ACF FINCO I LP
To: LIVANOVA USA, INC.
Reel/Frame 057552/0378 →
SECURITY INTEREST Recorded Aug 16, 2021
From: LIVANOVA USA, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 057188/0001 →
RELEASE OF SECURITY INTEREST Recorded Aug 16, 2021
From: ARES CAPITAL CORPORATION, AS AGENT FOR THE LENDERS
To: LIVANOVA USA, INC.
Reel/Frame 057189/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 30, 2020
From: LIVANOVA USA, INC.
To: ACF FINCO I LP, AS COLLATERAL AGENT
Reel/Frame 054881/0784 →
CHANGE OF NAME Recorded Jun 29, 2020
From: CYBERONICS, INC.
To: LIVANOVA USA, INC.
Reel/Frame 053306/0229 →
PATENT SECURITY AGREEMENT Recorded Jun 17, 2020
From: LIVANOVA USA, INC.
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 053673/0675 →